Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MGK (McLaughlin Gormley King Company) is a leading life science company specializing in the development and distribution of insect control solutions for public health, animal health, and crop protection. Founded in 1902 and headquartered in Minneapolis, the company is a pioneer in botanical insecticides, particularly those derived from pyrethrum. MGK's portfolio includes a wide range of synthetic and natural products designed to manage pests that threaten human health and food security. Now a subsidiary of Sumitomo Chemical, MGK continues to innovate in the field of entomology and chemical formulation to provide sustainable and effective pest management tools globally.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MGK.